Young adult e-cigarette use: A latent class analysis of device and flavor use, 2018-2019.


Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 11 2020
Historique:
received: 10 07 2020
revised: 19 08 2020
accepted: 23 08 2020
pubmed: 10 9 2020
medline: 13 4 2021
entrez: 9 9 2020
Statut: ppublish

Résumé

The myriad of e-cigarette devices and flavors used by young adults (YAs) complicates identification of the particular e-cigarette products that are associated with more frequent tobacco use and merit consideration for regulation. The current study used latent class analysis to identify distinct patterns of e-cigarette device and flavor use and evaluate their association with vaping and smoking frequency. Cross-sectional survey data (2018-2019) from a Southern California cohort were analyzed. YAs reporting past 30-day nicotine vaping (N = 550; M age = 19.2 years) self-reported e-cigarette device type/brand and flavor. Six device (e-cig/vape pen, mech mod, box mod, JUUL, non-JUUL pod, disposable) and three flavor (tobacco, mint/menthol, sweet/fruit) indicators were included in a latent class analysis. Past 30-day nicotine vaping and cigarette smoking frequency were assessed as correlates of device and flavor class membership. Three classes were identified: Any Pod-Mint/Menthol or Sweet/Fruit Flavor Users (prevalance:47%); Non-JUUL-Sweet/Fruit Flavor Users (28%); and Poly-Device-Poly-Flavor Users (25%). Greater frequency of vaping and smoking were associated with higher odds of belonging to the Poly-Device-Poly-Flavor Users class vs. the Any Pod-Mint/Menthol or Sweet/Fruit Flavor Users (vaping: aOR[95%CI] = 1.36[1.16, 1.59], p < .001; smoking: aOR[95%CI] = 1.25[1.02, 1.54], p = .03) and Non-JUUL-Sweet/Fruit Flavor Users (vaping: aOR[95%CI] = 1.30[1.10, 1.53], p < .01; smoking: aOR[95%CI] = 1.42[1.07, 1.88], p = .02) classes. Although YAs that predominately used pod devices alongside non-tobacco flavors were most common, YAs characterized by a proclivity toward using many different devices and flavors were appreciably prevalent and smoked and vaped more frequently. Regulations targeting a wide spectrum of vaping products may be optimal in protecting YA health.

Identifiants

pubmed: 32906038
pii: S0376-8716(20)30423-3
doi: 10.1016/j.drugalcdep.2020.108258
pmc: PMC7767583
mid: NIHMS1653178
pii:
doi:

Substances chimiques

Flavoring Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

108258

Subventions

Organisme : NIDA NIH HHS
ID : K01 DA042950
Pays : United States
Organisme : NIDA NIH HHS
ID : K24 DA048160
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA229617
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA180905
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Références

Drug Alcohol Depend. 2016 Nov 01;168:176-180
pubmed: 27676583
Subst Use Misuse. 2018 Oct 15;53(12):2017-2031
pubmed: 29624135
Addict Behav. 2020 Aug;107:106402
pubmed: 32224428
Curr Addict Rep. 2019 Jun;6(2):98-113
pubmed: 31453046
Prev Sci. 2019 Apr;20(3):305-309
pubmed: 30637671
Addict Behav. 2020 Sep;108:106459
pubmed: 32388394
Addiction. 2020 Dec;115(12):2197-2199
pubmed: 32307739
Nicotine Tob Res. 2015 Feb;17(2):150-7
pubmed: 25187061
Pediatrics. 2019 Jun;143(6):
pubmed: 31122947
Yale J Biol Med. 2015 Sep 03;88(3):279-87
pubmed: 26339211
Pediatrics. 2019 Nov;144(5):
pubmed: 31659004
Struct Equ Modeling. 2007;14(4):671-694
pubmed: 19953201
J Adolesc Health. 2020 Jul;67(1):46-52
pubmed: 32192827
N Engl J Med. 2014 Jan 23;370(4):293-5
pubmed: 24350902
JAMA Netw Open. 2018 Oct 5;1(6):e183518
pubmed: 30646245
Public Health Rep. 2019 May/Jun;134(3):282-292
pubmed: 30857471
JAMA Pediatr. 2017 Aug 1;171(8):788-797
pubmed: 28654986
Drug Alcohol Depend. 2019 Oct 1;203:99-106
pubmed: 31434028
Eval Health Prof. 2014 Jun;37(2):147-55
pubmed: 24492245
Tob Regul Sci. 2017 Jan;3(1):68-80
pubmed: 30713989
Tob Control. 2019 Mar;28(2):146-151
pubmed: 29853561
Subst Use Misuse. 2019;54(2):315-323
pubmed: 30380969
Drug Alcohol Depend. 2019 Sep 1;202:149-155
pubmed: 31351341
Nicotine Tob Res. 2018 Jan 5;20(2):271-274
pubmed: 28371890
Tob Control. 2020 Dec;29(e1):e127-e128
pubmed: 32273434
Pediatrics. 2020 May;145(5):
pubmed: 32253264
Addict Behav. 2016 Nov;62:35-41
pubmed: 27310032
JAMA Pediatr. 2017 Dec 1;171(12):1192-1199
pubmed: 29059261
JAMA Pediatr. 2020 Mar 1;174(3):277-286
pubmed: 31961395
Pediatrics. 2016 Dec;138(6):
pubmed: 27940718
Drug Alcohol Depend. 2009 Jun 1;102(1-3):78-87
pubmed: 19250776
PLoS One. 2019 Feb 27;14(2):e0212353
pubmed: 30811486
Drug Alcohol Depend. 2019 Jan 1;194:395-400
pubmed: 30497057
Drug Alcohol Depend. 2016 Sep 01;166:263-7
pubmed: 27426010
Nicotine Tob Res. 2020 Jun 12;22(7):1063-1076
pubmed: 31127298
Child Dev. 2007 Nov-Dec;78(6):1706-22
pubmed: 17988316
JAMA. 2019 Nov 5;:
pubmed: 31688912
Lancet Psychiatry. 2014 Dec;1(7):569-76
pubmed: 26361316
Drug Alcohol Depend. 2017 Nov 1;180:193-199
pubmed: 28915478
Tob Control. 2018 Oct;27(e2):e152-e159
pubmed: 29097588
N Engl J Med. 2018 Sep 20;379(12):1099-1102
pubmed: 30134127

Auteurs

H Isabella Lanza (HI)

Department of Human Development, California State University, Long Beach, CA 90840, USA. Electronic address: Isabella.Lanza@csulb.edu.

Adam M Leventhal (AM)

Department of Preventive Medicine, University of Southern California, Los Angeles, CA 90032, USA; Department of Psychology, University of Southern California, Los Angeles, CA 90033, USA; USC Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA.

Junhan Cho (J)

Department of Preventive Medicine, University of Southern California, Los Angeles, CA 90032, USA.

Jessica L Braymiller (JL)

Department of Preventive Medicine, University of Southern California, Los Angeles, CA 90032, USA.

Evan A Krueger (EA)

Department of Preventive Medicine, University of Southern California, Los Angeles, CA 90032, USA.

Rob McConnell (R)

Department of Preventive Medicine, University of Southern California, Los Angeles, CA 90032, USA.

Jessica L Barrington-Trimis (JL)

Department of Preventive Medicine, University of Southern California, Los Angeles, CA 90032, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH